Dr. David K. Chang
Dr David Chang is a surgeon scientist who specialises in the treatment of malignant pancreatic diseases. His research focus is on the development and implementation of novel therapeutic strategies for pancreatic cancer utilising molecular biomarkers of prognosis and therapeutic responsiveness. Dr Chang undertook his pancreatic surgical fellowship, PhD, and post-doctoral training in Australia. He was recruited to University of Glasgow 5 years ago as part of a initiative to implement precision medicine in West of Scotland and the UK. He co-leads of Precision-Panc, a pan-UK initiative to deliver personalized cancer care for pancreatic cancer, and is the chief investigator of its Master Protocol. He is also involved in the Precision Promise initiative, a Pancreatic Cancer Action Network (USA) initiative dedicated in delivering personalized treatment for patients with pancreatic cancer. Dr Chang also serves on the Scientific Planning Committee of ICGC for Medicine (ICGC ARGO), aiming to shaping the goals, and the future of the next generation cancer genomic projects to ultimately realize the goals and promises of precision medicine.